Buparvaquone Injection 5%
Buparvaquone is a second-generation hydroxynaphtaquinone with novel features that make it an effective compound for the therapy and prophylaxis of all forms of theileriosis.
Indications
For treatment of tick-transmitted theileriosis caused by the intracellular protozoan parasites Theileria parva (East Coast fever, Corridor disease, Zimbabwean theileriosis) and T. annulata (tropical theileriosis) in cattle. It is active against both the schizont and piroplasm stages of Theileria spp. and may be used during the incubation period of the disease, or when clinical signs are apparent.
Administration and Dosage
For intramuscular injection.
The general dosage is 1 ml per 20 kg bodyweight.
In severe cases the treatment may be repeated within 48 - 72 hours. Do not administer more than 10 ml per injection site. Successive injections should be administered at different sites.
Contraindications
Due to the inhibiting effects of theileriosis on the immune system, vaccination should be delayed until the animal has recovered from theileriosis.
Side Effects
Localised, painless, oedematous swelling may occasionally be seen at the injection site.
Withdrawal Period
- For meat : 42 days.
- For milk : 2 day
Storage
Store below 25ºC, in a cool and dry place, and protect from light.
For Veterinary Use Only
